Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Fertility‐sparing treatment demonstrated a 62.5% recurrence rate at 10 years. Recurrence was more likely in patients initially treated with megestrol acetate or those with a family history of cancer. As most patients lacked high‐risk molecular features, conservative treatment may remain a safe option for selected individuals under close long‐term ...
Ya‐Ting Hsu +4 more
wiley +1 more source
Clinical value of D-dimer combined with transvaginal ultrasonography in the postmenopausal population with endometrial carcinoma. [PDF]
Sci RepGuo X, Cheng Y, Du J.
europepmc +1 more source
Diagnosis of endometrial carcinoma and its related lesions by routine cervical cytology.
, 1989 Masahiro Tango, Kishichiro Watanabe
openalex +2 more sources
Mutations of the β‐Catenin Gene in Endometrial Carcinomas [PDF]
, 1999 Kanji Kobayashi +4 more
openalex +1 more source
A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer
BJU International, EarlyView.Objectives To evaluate the effect of metformin on non‐muscle‐invasive bladder cancer (NMIBC) marker lesions. Patients and methods A phase II, open‐label, multicentre, marker lesion trial using oral metformin in patients with primary or recurrent, multiple, low‐grade Ta‐T1 NMIBC was conducted. After transurethral resection for histological confirmation,
Jons W. van Hattum +12 more
wiley +1 more source
A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma: Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction [PDF]
, 1996 Britta Nordström +4 more
openalex +1 more source
British Journal of Pharmacology, EarlyView.Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley +1 more source
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma. [PDF]
Front PharmacolXie J +6 more
europepmc +1 more source
Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma [PDF]
, 1999 Makoto Saegusa +3 more
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source